ACTC

Advanced Cell exits Bay Area - 09/09 - 08:40 PM ET

Advanced Cell Technology Announces Cost Reduction Program - 09/09 - 09:38 AM ET

Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells - 08/19 - 03:09 PM ET

Beaufort mayor settles case - 07/17 - 02:33 PM ET

Rauch charged with insider trading, settles with SEC - 07/16 - 09:40 PM ET

Cloning technology could be used on humans - 04/15 - 02:21 AM ET

Advanced Cell Technology Platform Yields Over 140 Cell Types from Human Embryonic Stem Cells - 04/03 - 08:30 AM ET

ACTC: Completes $3.86M Private Placement of Secured Convertible Debentures - 04/01 - 08:37 AM ET

Advanced Cell Technology Completes Private Placement - 03/31 - 05:33 PM ET

ACT and Catholic Healthcare West sign clinical trial agreement - 03/17 - 03:29 PM ET

ACT and Catholic Healthcare West sign clinical trial agreement - 03/13 - 09:57 AM ET

ACTC: Clinical Agreement w/Catholic Healthcare West - 03/12 - 09:41 AM ET

Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement - 03/12 - 09:15 AM ET

Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for Advanced Cell Technology (OTCBB: ACTC) shareholders! - 02/29 - 10:55 AM ET

PHARMING GROUP INKS LICENSE DEAL WITH ADVANCED CELL TECHNOLOGY - 02/28 - 01:11 PM ET

Advanced Cell Technology Demonstrates Efficient Generation of Functional Hepatocytes (Liver Cells) From Human Embryonic Stem Cells - 02/21 - 12:00 PM ET

Advanced Cell Technology Announces Presentation of Results from Myoblast Study at ISCTR World Symposium - 02/11 - 09:13 AM ET

ACTC: Completes Pre-IND Discussions w/FDA re RPE Therapy - 02/01 - 09:36 AM ET

Advanced Cell Technology Announces Completion of Pre-IND Meeting with the FDA for RPE Therapy for the Treatment of Retinal Degenerative Disease - 02/01 - 09:28 AM ET

Simple protein helps human embryonic stem cells to thrive - 01/22 - 12:21 AM ET

Page 1 of 2     1  2      Previous  |  Next

<< Back to Stock Index